Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | DBL™ Zinc Chloride |
| Active Ingredient: | Zinc chloride 5.3mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Siegfried Hameln GmbH, Hameln Germany |
| Product: | Herceptin |
| Active Ingredient: | Trastuzumab 150mg |
| Dosage Form: | Powder for infusion concentrate |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, Oregon, United States of America |
| Product: | Herceptin |
| Active Ingredient: | Trastuzumab 440mg |
| Dosage Form: | Powder for infusion concentrate with diluent |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, California, United States of America Genentech Inc, Oregon, United States of America |
| Product: | Herclon |
| Active Ingredient: | Trastuzumab 150mg |
| Dosage Form: | Powder for infusion |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, Oregon, United States of America |
| Product: | Herclon |
| Active Ingredient: | Trastuzumab 440mg |
| Dosage Form: | Powder for infusion with diluent |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, California, United States of America Genentech Inc, Oregon, United States of America |
| Product: | Priadel |
| Active Ingredient: | Lithium carbonate 400mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | Clinect NZ Pty Limited |
| Manufacturer: | Delpharm Dijon, Quetigny, France |
| Product: | Solu-Medrol |
| Active Ingredient: | Methylprednisolone sodium succinate 1g |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer Manufacturing Belgium NV, Puurs, Belgium Pharmacia & Upjohn Company LLC, Michigan, United States of America |
| Product: | Solu-Medrol |
| Active Ingredient: | Methylprednisolone sodium succinate 2g |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer Manufacturing Belgium NV, Puurs, Belgium Pharmacia & Upjohn Company LLC, Michigan, United States of America |
| Product: | Solu-Medrol Act-O-Vial |
| Active Ingredient: | Methylprednisolone sodium succinate 40mg/mL |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer Manufacturing Belgium NV, Puurs, Belgium Pharmacia & Upjohn Company LLC, Michigan, United States of America |
| Product: | Solu-Medrol Act-O-Vial |
| Active Ingredient: | Methylprednisolone sodium succinate 62.5mg/mL |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer Manufacturing Belgium NV, Puurs, Belgium Pharmacia & Upjohn Company LLC, Michigan, United States of America |
| Product: | Solu-Medrol Act-O-Vial |
| Active Ingredient: | Methylprednisolone sodium succinate 728.67mg |
| Dosage Form: | Powder for injection with diluent |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturers: | Pfizer Manufacturing Belgium NV, Puurs, Belgium Pharmacia & Upjohn Company LLC, Michigan, United States of America |
Dated this 12th day of December 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).